Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients.

L. Dominioni, R. Dionigi, P. Dionigi, S. Nazari, G. S. Fossati, U. Prati, C. Tibaldeschi, F. Pavesi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The separate roles of malnutrition, advanced age, and stage of tumor growth as causes of impairment of delayed hypersensitivity response (DHR) was studied in 111 patients with solid tumors and in 56 nonneoplastic control patients matched for age, anatomical site of disease, degree of illness, and nutritional status. Pretreatment DHR to recall antigens (tuberculin, Candida, streptokinase-streptodornase, trichophyton) and to dinitrochlorobenzene in cancer patients with 9% anergic, 43% hypoergic, and 48% normoergic; the distribution of DHR in controls was not significantly different. In cancer patients, the serum albumin level showed an inverse correlation with the stage of tumor (p less than 0.01) and a positive correlation with the DHR (p less than 0.001); the serum albumin level was also in the controls positively correlated with the DHR (p less than 0.01), indicating that malnutrition in neoplastic or benign disease may cause depression of DHR. In well-nourished controls, age was inversely correlated with DHR (p less than 0.05), showing that aging itself may be another relevant cause of depression of DHR. The results of this study indicate that DHR in patients with solid tumors is similar to the DHR of nonneoplastic patients if matched for age, sex, and nutritional status. DHR impairment in cancer patients appears to be caused mainly by aging and by malnutrition due to the advanced progression of cancer.

Original languageEnglish
Pages (from-to)300-306
Number of pages7
JournalJournal of Parenteral and Enteral Nutrition
Volume5
Issue number4
Publication statusPublished - Jul 1981

Fingerprint

delayed hypersensitivity
Delayed Hypersensitivity
neoplasms
Neoplasms
Malnutrition
malnutrition
serum albumin
Nutritional Status
Serum Albumin
nutritional status
Streptodornase and Streptokinase
Dinitrochlorobenzene
Trichophyton
tuberculin
Tuberculin
Candida
pretreatment
antigens
Antigens

ASJC Scopus subject areas

  • Food Science
  • Medicine (miscellaneous)

Cite this

Dominioni, L., Dionigi, R., Dionigi, P., Nazari, S., Fossati, G. S., Prati, U., ... Pavesi, F. (1981). Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients. Journal of Parenteral and Enteral Nutrition, 5(4), 300-306.

Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients. / Dominioni, L.; Dionigi, R.; Dionigi, P.; Nazari, S.; Fossati, G. S.; Prati, U.; Tibaldeschi, C.; Pavesi, F.

In: Journal of Parenteral and Enteral Nutrition, Vol. 5, No. 4, 07.1981, p. 300-306.

Research output: Contribution to journalArticle

Dominioni, L, Dionigi, R, Dionigi, P, Nazari, S, Fossati, GS, Prati, U, Tibaldeschi, C & Pavesi, F 1981, 'Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients.', Journal of Parenteral and Enteral Nutrition, vol. 5, no. 4, pp. 300-306.
Dominioni, L. ; Dionigi, R. ; Dionigi, P. ; Nazari, S. ; Fossati, G. S. ; Prati, U. ; Tibaldeschi, C. ; Pavesi, F. / Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients. In: Journal of Parenteral and Enteral Nutrition. 1981 ; Vol. 5, No. 4. pp. 300-306.
@article{65066e2c29834dda8eed9e19adb9d42e,
title = "Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients.",
abstract = "The separate roles of malnutrition, advanced age, and stage of tumor growth as causes of impairment of delayed hypersensitivity response (DHR) was studied in 111 patients with solid tumors and in 56 nonneoplastic control patients matched for age, anatomical site of disease, degree of illness, and nutritional status. Pretreatment DHR to recall antigens (tuberculin, Candida, streptokinase-streptodornase, trichophyton) and to dinitrochlorobenzene in cancer patients with 9{\%} anergic, 43{\%} hypoergic, and 48{\%} normoergic; the distribution of DHR in controls was not significantly different. In cancer patients, the serum albumin level showed an inverse correlation with the stage of tumor (p less than 0.01) and a positive correlation with the DHR (p less than 0.001); the serum albumin level was also in the controls positively correlated with the DHR (p less than 0.01), indicating that malnutrition in neoplastic or benign disease may cause depression of DHR. In well-nourished controls, age was inversely correlated with DHR (p less than 0.05), showing that aging itself may be another relevant cause of depression of DHR. The results of this study indicate that DHR in patients with solid tumors is similar to the DHR of nonneoplastic patients if matched for age, sex, and nutritional status. DHR impairment in cancer patients appears to be caused mainly by aging and by malnutrition due to the advanced progression of cancer.",
author = "L. Dominioni and R. Dionigi and P. Dionigi and S. Nazari and Fossati, {G. S.} and U. Prati and C. Tibaldeschi and F. Pavesi",
year = "1981",
month = "7",
language = "English",
volume = "5",
pages = "300--306",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Evaluation of possible causes of delayed hypersensitivity impairment in cancer patients.

AU - Dominioni, L.

AU - Dionigi, R.

AU - Dionigi, P.

AU - Nazari, S.

AU - Fossati, G. S.

AU - Prati, U.

AU - Tibaldeschi, C.

AU - Pavesi, F.

PY - 1981/7

Y1 - 1981/7

N2 - The separate roles of malnutrition, advanced age, and stage of tumor growth as causes of impairment of delayed hypersensitivity response (DHR) was studied in 111 patients with solid tumors and in 56 nonneoplastic control patients matched for age, anatomical site of disease, degree of illness, and nutritional status. Pretreatment DHR to recall antigens (tuberculin, Candida, streptokinase-streptodornase, trichophyton) and to dinitrochlorobenzene in cancer patients with 9% anergic, 43% hypoergic, and 48% normoergic; the distribution of DHR in controls was not significantly different. In cancer patients, the serum albumin level showed an inverse correlation with the stage of tumor (p less than 0.01) and a positive correlation with the DHR (p less than 0.001); the serum albumin level was also in the controls positively correlated with the DHR (p less than 0.01), indicating that malnutrition in neoplastic or benign disease may cause depression of DHR. In well-nourished controls, age was inversely correlated with DHR (p less than 0.05), showing that aging itself may be another relevant cause of depression of DHR. The results of this study indicate that DHR in patients with solid tumors is similar to the DHR of nonneoplastic patients if matched for age, sex, and nutritional status. DHR impairment in cancer patients appears to be caused mainly by aging and by malnutrition due to the advanced progression of cancer.

AB - The separate roles of malnutrition, advanced age, and stage of tumor growth as causes of impairment of delayed hypersensitivity response (DHR) was studied in 111 patients with solid tumors and in 56 nonneoplastic control patients matched for age, anatomical site of disease, degree of illness, and nutritional status. Pretreatment DHR to recall antigens (tuberculin, Candida, streptokinase-streptodornase, trichophyton) and to dinitrochlorobenzene in cancer patients with 9% anergic, 43% hypoergic, and 48% normoergic; the distribution of DHR in controls was not significantly different. In cancer patients, the serum albumin level showed an inverse correlation with the stage of tumor (p less than 0.01) and a positive correlation with the DHR (p less than 0.001); the serum albumin level was also in the controls positively correlated with the DHR (p less than 0.01), indicating that malnutrition in neoplastic or benign disease may cause depression of DHR. In well-nourished controls, age was inversely correlated with DHR (p less than 0.05), showing that aging itself may be another relevant cause of depression of DHR. The results of this study indicate that DHR in patients with solid tumors is similar to the DHR of nonneoplastic patients if matched for age, sex, and nutritional status. DHR impairment in cancer patients appears to be caused mainly by aging and by malnutrition due to the advanced progression of cancer.

UR - http://www.scopus.com/inward/record.url?scp=0019590587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019590587&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 300

EP - 306

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 4

ER -